ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MXCT vs OABI // 10Y YIELD & FRED MACRO BETA

MaxCyte Inc. (NASDAQ) VS. OmniAb Inc. (NASDAQ) • 15-METRIC TALLY: MXCT 3 — OABI 4
■ METRIC PARITY
macro-sensitivity
—
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MXCT VS. OABI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MXCT OABI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 96.00% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -27.10% -22.60% -4.50 OABI /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -20.26% -4.87% -15.39 OABI /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -5.70% -29.30% +23.60 MXCT /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.52 12.19 -10.67 OABI /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 MXCT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 70.7 61.0 +9.70 MXCT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $178.5M $760.4M -$581.8M OABI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MXCT REV OABI REV MXCT GROSS % OABI GROSS % MXCT FCF OABI FCF
FY 2025 $21.0M $18.7M 98.0% — -$36.2M -$37.0M
FY 2024 $22.2M $26.4M 98.0% — -$29.3M -$41.5M
FY 2023 $19.5M $34.2M — — -$21.7M $2.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MXCT // BETA —
OABI // BETA —